Me. Fitzsimmons et al., NEPHROTOXICITY AND HEPATOTOXICITY OF 5,6-DICHLORO-4-THIA-5-HEXENOIC ACID - EVIDENCE FOR FATTY-ACID BETA-OXIDATION-DEPENDENT BIOACTIVATION, The Journal of pharmacology and experimental therapeutics, 271(1), 1994, pp. 515-523
5,6-Dichloro-4-thia-5-hexenoic acid (DCTH) is toxic to rat liver and k
idney mitochondria and is cytotoxic to isolated rat hepatocytes. The o
bject of this investigation was to test the hypothesis that DCTH is bi
oactivated in vivo by the enzymes of mitochondrial fatty acid beta oxi
dation and that the observed mitochondrial dysfunction is a consequenc
e of this bioactivation. DCTH was a potent nephrotoxin and hepatotoxin
in Long-Evans rats, whereas the odd-chain-length analog 6,7-dichloro-
5-thia-6-heptenoic acid was not toxic. DCTH produced morphological cha
nges in renal proximal convoluted tubules and the liver. The increases
in urinary protein, glucose and blood urea nitrogen concentrations we
re consistent with the renal lesions. Hepatic lesions were associated
with an increase in plasma glutamate-pyruvate transaminase activity, a
marked infiltration of lipid and depletion of glycogen concentrations
. A pronounced decrease in plasma glucose concentrations was also obse
rved. DCTH decreased fatty acid beta oxidation by 75% and 40% in liver
and kidney mitochondria, respectively, isolated from DCTH-treated rat
s. in addition, medium-chain acyl-coenzyme A dehydrogenase activity wa
s reduced by 25% in rat liver mitochondria incubated with DCTH. The da
ta presented are consistent with the hypothesis that DCTH is bioactiva
ted by the mitochondrial fatty acid beta-oxidation system and that mit
ochondria are a critical cellular target in DCTH-induced toxicity.